During the past decade, University of Maryland Eye Associates conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Maryland Eye Associates" #1 collaborator was "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Maryland Eye Associates" are "Diabetic Macular Edema (DME)" (1 trials) and "Persistent Corneal Epithelial Defect" (1 trials). Many other conditions were trialed in "University of Maryland Eye Associates" in a lesser frequency.

Most popular intervention types in "University of Maryland Eye Associates" are "Biological" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.67% Sodium Chloride Ophthalmic Solution" (1 trials), "ILUVIEN 0.19 MG" (1 trials), "Open-label ST266" (1 trials) and "ST266" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Maryland Eye Associates" are 2 trials for "All" genders.

Currently, there are NaN active trials in "University of Maryland Eye Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Maryland Eye Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Maryland Eye Associates, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".